Phase II study of TS-1 for patients with advanced non-small cell lung cancer treated with prior chemotherapy.

Phase II study of TS-1 for patients with advanced non-small cell lung cancer treated with prior chemotherapy. - Phase II study of TS-1 for patients with advanced non-small cell lung cancer treated with prior chemotherapy.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000000817

Enrollment

Registered

2007-09-05

Start date

2007-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

June, 2007-December, 2008 Regimen: TS-1

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Non-small cell lung cancer 2) Stage IIIB or IV 3) Performance status(ECOG) 0-1 4) Prior chemotherapy 5) Adequate haematopoietic function 6) Adequate liver and renal function 7) Each patient signed a written informed consent

Exclusion criteria

Exclusion criteria: 1) Massive pleural effusion 2) Massivepericardial effusion 3) Interstitial pneumonitis 4) Uncontrolled brain metastasis 5) Active infection

Design outcomes

Primary

Measure	Time frame
Response rate, time to progression, toxicity	—

Countries

Japan

Contacts

Public ContactTakashi Kasai

Japanese Red Cross Nagasaki Atomic Bomb Hospital Internal Medicine

takasai@tochigi-cc.jp095-847-1511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026